Maintenance therapy in adults with metastatic cancer that has not progressed after first-line therapy with platinum chemotherapy and has certain germline mutations in the BRCA1 or BRCA2 gene. The gene discussed is BRCA2; the disease is metastatic malignant neoplasm.